Stocktwits on MSN

Alto Neuroscience Stock Soars After FDA Grants Fast Track Designation To Schizophrenia Drug

Shares of Alto Neuroscience (ANRO) soared 54% on Friday afternoon after the company announced that the U.S. Food and Drug ...
The Caledonian-Record

Alto Neuroscience Receives FDA Fast Track Designation for ALTO-101 for the Treatment of Cognitive Impairment Associated with Schizophrenia

Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced that ...
News-Medical.Net on MSN

COMBINEDBrain and MUSC join forces to launch pediatric CNS biorepository

COMBINEDBrain, a leader in advancing translational neuroscience research, and the Medical University of South Carolina (MUSC), one of the nation's premier academic health centers, are excited to ...
Nature

Motac Neuroscience Ltd.

Article ‘Count’ and ‘Share’ for Motac Neuroscience Ltd. based on listed parameters only. The articles listed below published by authors from Motac Neuroscience Ltd., organized by journal and article, ...